11C-蛋氨酸PET-CT显像对术后持续或复发性库欣病的诊断价值
该回顾性研究分析了2个三级医疗中心2002年5月至2023年11月间22例经蝶手术后持续或复发性库欣病且垂体MRI模棱两可或阴性的患者,评估11C-蛋氨酸PET/CT定位残留或复发促肾上腺皮质激素腺瘤的诊断效用。14例(63.5%)在可疑区域发现最大代谢活性,基于阳性影像12例再次经蝶手术(7例成功)、2例接受伽玛刀放射外科(均缓解),总缓解率64%;阳性11C-MET PET/CT检出准确率为86%(12/14)。
要点
- 22例术后持续/复发库欣病且MRI模棱两可或阴性患者中,14例(63.5%)11C-MET PET/CT显示可疑区域最大代谢活性。
- 基于阳性影像行再次经蝶手术12例中7例成功,伽玛刀2例均缓解,总缓解率64%。
- 阳性11C-MET PET/CT检出促肾上腺皮质激素腺瘤的准确率为86%(12/14)。
核心结论
- 11C-MET PET/CT显像可在超过半数术后持续/复发库欣病且MRI模棱两可或阴性的患者中检出促肾上腺皮质激素微腺瘤,为靶向经蝶手术或放射外科提供有价值的诊断信息,阳性影像亚组总成功率为64%。
研究设计与样本
- 回顾性分析2个三级医疗中心2002年5月至2023年11月间22例初次经蝶手术后持续/复发库欣病且垂体MRI模棱两可或阴性患者的11C-MET PET/CT结果;15例将11C-MET PET/CT图像与高分辨率3D T1或FLAIR垂体MRI共配准。
- 患者中18例女性,诊断时平均年龄36岁,初始肿瘤最大径平均6.5 mm。
主要发现
- 22例中13例常规MRI有可疑异常、9例MRI阴性;14例(63.5%)在可疑区域发现最大代谢活性(SUVmaxT),其中9例MRI阴性者中5例、13例模棱两可者中9例。
- 基于阳性影像,12例接受再次经蝶手术、7例成功,2例接受伽玛刀放射外科、均缓解,总缓解率64%。
- 再次经蝶手术未治愈的5例中,3例切除组织中发现促肾上腺皮质激素腺瘤。
- 阳性11C-MET PET/CT检出率准确度为86%(12/14)。
- 8例PET阴性患者中,2例接受探查性经蝶手术均未缓解,2例接受伽玛刀放射外科、1例长期缓解。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Equivocal or negative pituitary magnetic resonance imaging (MRI) findings pose a significant challenge in the management of persistent or recurrent Cushing disease (CD), compromising the chances of success of further transsphenoidal surgery (TSS). OBJECTIVE: To determine the diagnostic utility of 11C-methionine (11C-MET) positron emission tomography/computerized tomography (PET/CT) in localizing residual or relapsing corticotroph adenoma. METHODS: We retrospectively analyzed the results of all 11C-MET PET/CT performed at 2 tertiary medical centers between May 2002 and November 2023 in 22 patients with persistent/recurrent CD after initial TSS and equivocal/negative pituitary MRI. In 15 cases, 11C-MET PET/CT images were also co-registered with high-resolution 3D T1 or FLAIR MRI pituitary imaging. RESULTS: Of 22 patients (18 female; mean age 36 years at diagnosis; mean initial tumor maximum diameter 6.5 mm), 13 had a suspect anomaly on conventional MRI and 9 had a negative MRI. Maximal metabolic activity in the suspect area (SUVmaxT) was found in 14 patients (63.5%; 5/9 patients with negative pituitary MRI and 9/13 with equivocal findings). Based on positive imaging, 12 patients underwent repeat TSS, successful in 7, while 2 patients underwent Gamma Knife radiosurgery (GKRS), both resulting in remission (total remission rate of 64%). Among the 5 patients not cured by TSS, the presence of corticotroph adenoma in the resected tissue was found in 3 cases. Positive 11C-MET PET/CT had a detection rate accuracy of 86% (12/14). Of the 8 PET-negative patients, 2 underwent exploratory TSS, with no remission, and 2 underwent GKRS, with 1 long-term remission. CONCLUSION: 11C-MET PET/CT imaging can provide valuable diagnostic information to detect a corticotroph microadenoma in more than half of patients with persistent/recurrent CD and equivocal or negative MRI findings, allowing targeted TSS or radiosurgery with a global success rate of 64% in the selected subgroup with positive imaging.
引用
- Furnica RM, Devuyst F, Mathey C, et al. Diagnostic Value of 11C-Methionine PET-CT Imaging in Persistent or Recurrent Cushing Disease After Surgery. J Clin Endocrinol Metab. 2025. PMID: 39873396. doi:10.1210/clinem/dgaf047
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。